A Bioavailability Study of Two Different PEG-rhGH Preparations.
Clinical trial NCT06385145 · COMPLETED
Trial details
- NCT number
- NCT06385145
- Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-08
- Primary completion
- 2024-07-05
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.